Literature DB >> 15526170

Modulation of SMN nuclear foci and cytoplasmic localization by its C-terminus.

Y Hua1, J Zhou.   

Abstract

The survival of motor neuron ( SMN1) gene product, SMN, is detected both in the cytoplasm and in nuclear gems and cajal bodies. We show here that SMN exon 6 is essential both for formation of its nuclear foci and for its cytoplasmic localization. However, exon 7 inhibits the formation of SMN nuclear foci but promotes SMN cytoplasmic localization. More interestingly, we find that a random C-terminal tag of five or more amino acids downstream of exon 6 is sufficient to inhibit the occurrence of multiple nuclear foci and to promote cytoplasmic localization of SMNDelta7, the primary product of the SMN2 gene. Moreover, SMNDelta7 proteins that bear spinal muscular atrophy mutations in exon 6 either showed defects in nuclear foci formation or enhanced cytoplasmic localization. We conclude that exon 6 and exon 7 synergistically regulate SMN distribution that may require specific exon 6 motifs but is independent of specific sequences in exon 7.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526170     DOI: 10.1007/s00018-004-4300-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  13 in total

1.  Analysis of a read-through promoting compound in a severe mouse model of spinal muscular atrophy.

Authors:  Virginia B Mattis; Cheng-Wei Tom Chang; Christian L Lorson
Journal:  Neurosci Lett       Date:  2012-07-20       Impact factor: 3.046

Review 2.  Assays for the identification and prioritization of drug candidates for spinal muscular atrophy.

Authors:  Jonathan J Cherry; Dione T Kobayashi; Maureen M Lynes; Nikolai N Naryshkin; Francesco Danilo Tiziano; Phillip G Zaworski; Lee L Rubin; Jill Jarecki
Journal:  Assay Drug Dev Technol       Date:  2014-08       Impact factor: 1.738

Review 3.  Spinal muscular atrophy: mechanisms and therapeutic strategies.

Authors:  Christian L Lorson; Hansjorg Rindt; Monir Shababi
Journal:  Hum Mol Genet       Date:  2010-04-13       Impact factor: 6.150

4.  A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy.

Authors:  Xingxing Wu; Shu-Huei Wang; Junjie Sun; Adrian R Krainer; Yimin Hua; Thomas W Prior
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

5.  Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.

Authors:  Virginia B Mattis; Ravi Rai; Jinhua Wang; Cheng-Wei T Chang; Tristan Coady; Christian L Lorson
Journal:  Hum Genet       Date:  2006-09-02       Impact factor: 4.132

Review 6.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

7.  Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model.

Authors:  Virginia B Mattis; Allison D Ebert; Marina Y Fosso; Cheng-Wei Chang; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2009-07-21       Impact factor: 6.150

8.  A positive modifier of spinal muscular atrophy in the SMN2 gene.

Authors:  Thomas W Prior; Adrian R Krainer; Yimin Hua; Kathryn J Swoboda; Pamela C Snyder; Scott J Bridgeman; Arthur H M Burghes; John T Kissel
Journal:  Am J Hum Genet       Date:  2009-08-27       Impact factor: 11.025

9.  Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.

Authors:  Yimin Hua; Timothy A Vickers; Hazeem L Okunola; C Frank Bennett; Adrian R Krainer
Journal:  Am J Hum Genet       Date:  2008-03-27       Impact factor: 11.025

10.  Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA.

Authors:  Virginia B Mattis; Marina Y Fosso; Cheng-Wei Chang; Christian L Lorson
Journal:  BMC Neurosci       Date:  2009-11-30       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.